Insider · CIK 0001218483
Kevin K Gordon
Files at PGNY (Progyny, Inc.). First filing Dec 13, 2023, latest Sep 18, 2026.
In brief
Kevin K Gordon files SEC Form 4 as director at PGNY (Progyny, Inc.). Since Dec 13, 2023, Kevin K Gordon has reported 0 open-market buys worth $0 and 5 open-market sells worth $916k, the latest filed on Sep 18, 2026.
A track record needs three past buys with six months of prices behind them; Kevin K Gordon has 0, so none is measured yet.
The newest scored trade: sold $312k of PGNY on Sep 10, 2026, filed Sep 18, 2026, scored 42 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $771k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PGNY: Progyny, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Progyny, Inc. | $312k 11,500 shares | -63% | +66% from low-16% from high | |
| 42Moderate | Progyny, Inc. | $321k 11,500 shares | -63% | +66% from low-16% from high | |
| 51Moderate | Progyny, Inc. | $137k 5,500 shares | -37% | +56% from low-10% from high | |
| 27Weak | PGNYsell Progyny, Inc. | $55k 2,500 shares | -17% | +59% from low-12% from high | |
| 44Moderate | Progyny, Inc. | $90k 2,500 shares | -20% | +28% from low-16% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 10, 2026 | PGNY Progyny, Inc. | 11,500 0.01% of outstanding | $312k | Sep 10, 2026 | none |
| May 27, 2026 | PGNY Progyny, Inc. | 5,500 0.01% of outstanding | $137k | May 27, 2026 | none |
| Aug 11, 2025 | PGNY Progyny, Inc. | 2,500 0.00% of outstanding | $55k | Aug 11, 2025 | none |
| Dec 11, 2023 | PGNY Progyny, Inc. | 2,500 0.00% of outstanding | $90k | Dec 11, 2023 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | PGNY Progyny, Inc. | MOption exercise Common Stock | +22,000 | $13.00 | $286k | 28,792 | 25 d ago |
| Sep 10, 2026 | PGNY Progyny, Inc. | FTax withholding Common Stock | -10,500 | $27.24 | $286k | 18,292 | 25 d ago |
| Sep 10, 2026 | PGNY Progyny, Inc. | SOpen-market sale Common Stock | -11,500 | $27.12 | $312k | 6,792 | 25 d ago |
| Sep 10, 2026 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -22,000 | $0.00 | $0 | 22,000 | 25 d ago |
| Sep 10, 2026 | PGNY Progyny, Inc. | MOption exercise Common Stock | +22,000 | $13.00 | $286k | 28,792 | 29 d ago |
| Sep 10, 2026 | PGNY Progyny, Inc. | FTax withholding Common Stock | -10,500 | $27.24 | $286k | 18,292 | 29 d ago |
| Sep 10, 2026 | PGNY Progyny, Inc. | SOpen-market sale Common Stock | -11,500 | $27.94 | $321k | 6,792 | 29 d ago |
| Sep 10, 2026 | PGNY Progyny, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -22,000 | $0.00 | $0 | 22,000 | 29 d ago |
| May 27, 2026 | PGNY Progyny, Inc. | SOpen-market sale Common Stock | -5,500 | $24.99 | $137k | 9,318 | May 29, 2026 |
| May 27, 2026 | PGNY Progyny, Inc. | JOther Common Stock | -2,526 | $0.00 | $0 | 6,792 | May 29, 2026 |
| May 27, 2026 | PGNY Progyny, Inc. | JOther Common Stockindirect: See footnote | +2,526 | $0.00 | $0 | 15,027 | May 29, 2026 |
| May 21, 2026 | PGNY Progyny, Inc. | AGrant or award Common Stock | +6,792 | $0.00 | $0 | 14,818 | May 26, 2026 |
| May 21, 2026 | PGNY Progyny, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,373 | $0.00 | $0 | 30,373 | May 26, 2026 |
| Aug 11, 2025 | PGNY Progyny, Inc. | SOpen-market sale Common Stockindirect: See footnote | -2,500 | $22.04 | $55k | 12,501 | Aug 13, 2025 |
| May 22, 2025 | PGNY Progyny, Inc. | AGrant or award Common Stock | +8,026 | $0.00 | $0 | 13,173 | May 27, 2025 |
| May 22, 2025 | PGNY Progyny, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +34,049 | $0.00 | $0 | 34,049 | May 27, 2025 |
| May 22, 2025 | PGNY Progyny, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +6,600 | $0.00 | $0 | 6,600 | May 27, 2025 |
| Dec 11, 2023 | PGNY Progyny, Inc. | SOpen-market sale Common Stock | -2,500 | $35.93 | $90k | 9,854 | Dec 13, 2023 |
Questions about Kevin K Gordon
Answered from the filings on this page, as of the latest one.
Is Kevin K Gordon buying or selling?
In the last 12 months Kevin K Gordon reported 0 open-market buys worth $0 and 3 open-market sells worth $771k on SEC Form 4; the latest was sold $312k of PGNY on Sep 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Kevin K Gordon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin K Gordon has 0.
Where does Kevin K Gordon file Form 4?
Kevin K Gordon has filed Form 4 at PGNY (Progyny, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.